In slow-growing and metabolically constrained tumors such as GBM and chondrosarcoma, chronic replication stress places the DNA damage response near its tolerance threshold; thus, additional ATR inhibition precipitates replication collapse and cell death, amplifying the therapeutic effect. The gene discussed is ATR; the disease is glioblastoma.